The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study

The Therapeutic Effect of a Multistrain Probiotic on Diarrhea-Predominant Irritable Bowel Syndrome: A Pilot Study

Backgrounds. Recent studies suggest that diarrhea-predominant irritable bowel syndrome (IBS) is associated with intestinal bacterial microflora, colonic inflammation, and small intestinal bacterial overgrowth (SIBO). The purpose of this study was to evaluate the effect of a multistrain probiotic int...

Full description

Saved in:

Bibliographic Details
Main Authors:	Seok-Hoon Lee, Nam-Seok Joo, Kwang-Min Kim, Kyu-Nam Kim
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Gastroenterology Research and Practice
Online Access:	http://dx.doi.org/10.1155/2018/8791916
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acupuncture for Adults with Diarrhea-Predominant Irritable Bowel Syndrome or Functional Diarrhea: A Systematic Review and Meta-Analysis
by: Jianbo Guo, et al.
Published: (2020-01-01)

Altered Intestinal Microbiota with Increased Abundance of Prevotella Is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome
by: Tingting Su, et al.
Published: (2018-01-01)

RETRACTED: Effect of acupuncture combined with Astragalus injection on peripheral blood inflammatory factors in children with diarrhea-predominant irritable bowel syndrome
by: Huimin Xue, et al.
Published: (2019-06-01)

Wuling powder ameliorates diarrhea-predominant irritable bowel syndrome in mice by modulating gut mucosal microbiota and alleviating intestinal inflammation
by: Qianghong Tian, et al.
Published: (2025-08-01)

Lack of Association Found between Helicobacter pylori Infection and Diarrhea-Predominant Irritable Bowel Syndrome: A Multicenter Retrospective Study
by: Feng Xiong, et al.
Published: (2016-01-01)

Abnormal Uroguanylin Immunoreactive Cells Density in the Duodenum of Patients with Diarrhea-Predominant Irritable Bowel Syndrome Changes following Fecal Microbiota Transplantation
by: Tarek Mazzawi, et al.
Published: (2020-01-01)

Irritable bowel syndrome in children: probiotics and vitamins
by: A. V. Gorelov, et al.
Published: (2021-06-01)

Treatment of autonomous intestinal neuropathy in critical care by prucalopride and multistrain probiotic
by: A. L. Kovaleva, et al.
Published: (2018-08-01)

Scutellaria baicalensis extracts alleviate zymosan-induced irritable bowel syndrome symptoms by modulating inflammation and ion channel activity
by: Na Ri Choi, et al.
Published: (2025-12-01)

Effect of single versus multistrain probiotic in extremely preterm infants: a randomised trial
by: Gayatri Athalye-Jape, et al.
Published: (2022-09-01)

Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
by: Dan-Yan Li, et al.
Published: (2017-01-01)

Efficacy and Mechanism of Trimebutine Maleate Combined with Lactulose in the Treatment of Constipation-Predominant Irritable Bowel Syndrome in the Elderly
by: Yeping Zhou, et al.
Published: (2022-01-01)

Functional Constipation and Constipation-Predominant Irritable Bowel Syndrome in the General Population: Data from the GECCO Study
by: Paul Enck, et al.
Published: (2016-01-01)

Improving the survival under gastric conditions of a potential multistrain probiotic produced in co-culture
by: Marcelo Fernando Valle-Vargas, et al.
Published: (2025-02-01)

Single Nucleotide Polymorphisms, Associated with Increased Risk of Irritable Bowel Syndrome with Predominant Constipation: A Meta Analysis
by: E. A. Trush, et al.
Published: (2024-08-01)

Multistrain Probiotics and Telomere Length in Type 2 Diabetes: A 24-Week Randomized Controlled Trial
by: Venkata Chaithanya, et al.
Published: (2025-02-01)

Impact of Multistrain Probiotic Supplementation on Glycemic Control in Type 2 Diabetes Mellitus—Randomized Controlled Trial
by: Venkata Chaithanya, et al.
Published: (2024-11-01)

Choice of treatment tactics in patients with acute diarrhea of bacterial etiology at high risk of irritable bowel syndrome
by: Mrs Roza Tlyustangelova, et al.
Published: (2025-03-01)

Clinical practice guidelines for the diagnosis of constipation-predominant irritable bowel syndrome and functional constipation in adults: a scoping review
by: Jingyuan Luo, et al.
Published: (2025-04-01)

NANOVESICLES IN THE GUT–BRAIN AXIS: INSIGHTS FROM PROBIOTIC SUPPLEMENTATION IN IRRITABLE BOWEL SYNDROME
Published: (2025-08-01)

Possibilities of modern probiotic therapy in the treatment of patients with post-infectious irritable bowel syndrome
by: V. A. Akhmedov, et al.
Published: (2022-02-01)

Role of Low FODMAP Diet and Probiotics on Gut Microbiome in Irritable Bowel Syndrome (IBS)
by: Shabnam Mohajir Selvaraj, et al.
Published: (2020-04-01)

Review of the Latest Therapeutic Approaches in the Management of Irritable Bowel Syndrome
by: Martyna Mrozek, et al.
Published: (2025-03-01)

Impact of multistrain probiotics on growth performance, immune response, and gut morphometry in broiler chicken Gallus gallus domesticus
by: Samina Younas, et al.
Published: (2025-05-01)

The Irritable Bowel Syndrome
by: N.B. Hershfield
Published: (1988-01-01)

Irritable Bowel Syndrome
by: Per G. Farup, et al.
Published: (2012-01-01)

Retracted: Association of Fecal Microbiota with Irritable Bowel Syndrome-Diarrhea and Effect of Traditional Chinese Medicine for Its Management
by: Gastroenterology Research and Practice
Published: (2024-01-01)

Male Patients Visited the Hospital With Diarrhea and Weight Loss
by: Ju Seok Kim
Published: (2024-06-01)

Reclamation of Herb Residues Using Probiotics and Their Therapeutic Effect on Diarrhea
by: Fanjing Meng, et al.
Published: (2017-01-01)

Therapeutic Potential of Flavonoids and Flavonoid-Rich Compounds in Irritable Bowel Syndrome
by: Xia Y, et al.
Published: (2025-06-01)

The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics
by: Yucui Zhao, et al.
Published: (2024-12-01)

Efficacy of Fecal Microbial Transplantation for Improving Symptoms of Irritable Bowel Syndrome - A Pilot Study for Voluntary Participants in Korea
by: Jung Won Lee, et al.
Published: (2024-10-01)

IRRITATED BOWEL SYNDROME IN CHILDREN
by: V. F. Privorotskiy, et al.
Published: (2012-05-01)

Determination of Probiotics Prescription Indications in Patients with Irritable Bowel Syndrome (Materials of the Expert Council and Literature Review)
by: V. T. Ivashkin, et al.
Published: (2022-08-01)

Tight junction protein changes in irritable bowel syndrome: the relation of age and disease severity
by: Sang Un Kim, et al.
Published: (2024-11-01)

Probiotics, Symptoms, and Gut Microbiota: What Are the Relations? A Randomized Controlled Trial in Subjects with Irritable Bowel Syndrome
by: Per G. Farup, et al.
Published: (2012-01-01)

The possibility of Bacillus probiotic use in patients with post-infectious irritable bowel syndrome after COVID-19 infection
by: I.Ya. Hospodarskyy, et al.
Published: (2024-06-01)

Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of <i>Clostridium butyricum</i> CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional Study
by: Francesco Di Pierro, et al.
Published: (2025-05-01)

Diagnosis and Treatment of the Irritable Bowel Syndrome
by: H.R. Schneider
Published: (2005-05-01)

Management of Irritable Bowel Syndrome in the Elderly
by: Indra Kurniawan, et al.
Published: (2016-05-01)